Quantcast
Last updated on April 17, 2014 at 21:23 EDT

Latest aplastic anemia Stories

2014-01-27 12:30:00

HOUSTON, Jan. 27, 2014 /PRNewswire-USNewswire/ -- Texas Children's Cancer and Hematology Centers hosted a first-of-its-kind symposium focusing on pediatric bone marrow failure, bringing together more than 20 experts from around the nation to collaborate, discuss their research interests and develop research goals. Led by Dr. Alison Bertuch, pediatric hematologist at Texas Children's Hospital and associate professor of pediatrics at Baylor College of Medicine, the symposium was made...

2012-07-05 10:22:42

Eltrombopag, a drug that was designed to stimulate production of platelets from the bone marrow and thereby improve blood clotting, can raise blood cell levels in some people with severe aplastic anemia who have failed all standard therapies. About one-third of aplastic anemia cases do not respond to standard therapy, a combination of immune-suppressing drugs. Although bone marrow stem cell transplantation is an option for some, patients without a matched donor have few treatment options....

2012-06-19 10:22:52

When a North Carolina girl's body starts attacking itself out of the blue, a horse steps in to save her life WASHINGTON, June 19, 2012 /PRNewswire-USNewswire/ -- FBR Media and executive producer Frankie Trull announced today the world premiere of their made-for-television documentary "Liviya's Story" on NBC 17 (WNCN) on June 21, 2012, at 11:30 AM EDT. "Liviya's Story" is the latest episode in FBR Media's Bench to Bedside TV series. With this distinguished documentary, FBR Media brings to...

2012-06-13 02:26:59

ROCKVILLE, Md., June 13, 2012 /PRNewswire/ -- This week's announcement by ABC News' Robin Roberts that she has been diagnosed with MDS (myelodysplastic syndrome) has drawn national attention to this bone marrow failure disorder. Since 1983, the Aplastic Anemia & MDS International Foundation (www.AAMDS.org) has provided education and support to patients with MDS. MDS is a group of rare disorders affecting the bone marrow. People with MDS have an abnormal number of red and white blood...

2012-04-02 15:43:29

New research in mice published in the Journal of Leukocyte Biology suggests that the platelet activating factor receptor plays a role in graft-versus-host disease, a major complication of bone marrow transplants A new discovery in mice may lead to new treatments that could make bone marrow transplants more likely to succeed and to be significantly less dangerous. According to new research findings published in the Journal of Leukocyte Biology (https://www.jleukbio.org) Brazilian scientists...

2012-02-02 23:12:14

Being anemic could more than triple your risk of dying within a year after having a stroke, according to research presented at the American Stroke Association's International Stroke Conference 2012. "Among stroke patients, severe anemia is a potent predictor of dying throughout the first year after a stroke," said Jason Sico, M.D., lead researcher and an assistant professor of neurology at Yale University School of Medicine in New Haven, Conn. Anemia is a common condition in which the...

2011-12-12 15:31:26

Hematopoietic cell transplantation (HCT), the transplantation of blood-forming stem cells from the bone marrow, peripheral blood, or umbilical cord blood, is the primary option for treatment for many patients who suffer from various hematologic disorders, including blood cancers, sickle cell disease, bone marrow deficiencies, bleeding disorders, and autoimmune disorders. Research investigating breakthroughs in hematopoietic cell transplantation will be presented today at the 53rd Annual...

2011-12-06 10:00:00

<font size="2" face="Arial"> </font> <font size="2" face="Arial">ROCKVILLE, Md.</font>, Dec. 6, 2011 /PRNewswire/ -- The Aplastic Anemia & MDS International Foundation (AA&MDSIF) is pleased to announce the launch of the Treating MDS Toolkit, a new, free resource developed for health care providers to communicate with and support their patients with myelodysplastic syndromes (MDS). The toolkit was developed in response to the results of an MDS patient...

2011-08-04 13:01:13

A comparison clinical study of two aplastic anemia treatments found that ATGAM, currently the only licensed aplastic anemia drug in the United States, improved blood cell counts and survival significantly more than did Thymoglobulin, a similar but reportedly more potent treatment. The research was funded by the National Heart, Lung, and Blood Institute (NHLBI), a part of the National Institutes of Health; the study participants were treated and then followed at the NIH Clinical Center in...

2011-07-07 19:00:43

Identifying a suitable donor for leukemia and lymphoma patients who need bone marrow transplants may be far easier now that results of two clinical trials show transplant results with half-matched bone marrow or umbilical cord blood are comparable to fully matched tissue, thanks in large part to the availability of effective antirejection drugs and special post-transplant chemotherapy. The finding means that nearly all patients in need of a transplant can find donors, according to Johns...